Does CIFENLINE Cause Interstitial lung disease? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with CIFENLINE. This represents 6.9% of all adverse event reports for CIFENLINE.
5
Reports of Interstitial lung disease with CIFENLINE
6.9%
of all CIFENLINE reports
2
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From CIFENLINE?
Of the 5 reports, 2 (40.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CIFENLINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CIFENLINE Cause?
Hypoglycaemia (10)
Arrhythmia (7)
Orthostatic hypotension (7)
Cardiac failure (6)
Hepatocellular injury (6)
Altered state of consciousness (5)
Cholestasis (5)
Condition aggravated (5)
Hepatitis acute (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)